Citation: Mb. Sporn et al., Prospects for prevention and treatment of cancer with selective PPAR gammamodulators (SPARMs), TRENDS MO M, 7(9), 2001, pp. 395-400
Authors:
Shaker, MR
Yang, G
Timme, TL
Park, SH
Kadmon, D
Ren, CZ
Ji, XR
Lee, HM
Sehgal, I
Anzano, M
Sporn, MB
Thompson, TC
Citation: Mr. Shaker et al., Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression, CLIN EXP M, 18(5), 2001, pp. 429-438
Authors:
Ito, Y
Pandey, P
Sporn, MB
Datta, R
Kharbanda, S
Kufe, D
Citation: Y. Ito et al., The novel triterpenoid CDDO induces apoptosis and differentiation of humanosteosarcoma cells by a caspase-8 dependent mechanism, MOLEC PHARM, 59(5), 2001, pp. 1094-1099
Authors:
Suh, N
Glasebrook, AL
Palkowitz, AD
Bryant, HU
Burris, LL
Starling, JJ
Pearce, HL
Williams, C
Peer, C
Wang, YP
Sporn, MB
Citation: N. Suh et al., Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancer, CANCER RES, 61(23), 2001, pp. 8412-8415
Authors:
Mix, KS
Mengshol, JA
Benbow, U
Vincenti, MP
Sporn, MB
Brinckerhoff, CE
Citation: Ks. Mix et al., A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines, ARTH RHEUM, 44(5), 2001, pp. 1096-1104
Authors:
Ito, Y
Pandey, P
Place, A
Sporn, MB
Gribble, GW
Honda, T
Kharbanda, S
Kufe, D
Citation: Y. Ito et al., The novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid induces apoptosis of human myeloid leukemia cells by a caspase-8-dependent mechanism, CELL GROWTH, 11(5), 2000, pp. 261-267
Citation: Yp. Wang et al., A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma, MOL ENDOCR, 14(10), 2000, pp. 1550-1556
Authors:
Honda, T
Gribble, GW
Suh, N
Finlay, HJ
Rounds, BV
Bore, L
Favaloro, FG
Wang, YP
Sporn, MB
Citation: T. Honda et al., Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages, J MED CHEM, 43(9), 2000, pp. 1866-1877
Authors:
Honda, T
Rounds, BV
Bore, L
Finlay, HJ
Favaloro, FG
Suh, N
Wang, YP
Sporn, MB
Gribble, GW
Citation: T. Honda et al., Synthetic oleanane and ursane triterpenoids with modified rings A and C: Aseries of highly active inhibitors of nitric oxide production in mouse macrophages, J MED CHEM, 43(22), 2000, pp. 4233-4246
Authors:
Subbaramaiah, K
Michaluart, P
Sporn, MB
Dannenberg, AJ
Citation: K. Subbaramaiah et al., Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells, CANCER RES, 60(9), 2000, pp. 2399-2404
Authors:
Veronesi, U
De Palo, G
Marubini, E
Costa, A
Formelli, F
Mariani, L
Decensi, A
Camerini, T
Del Turco, MR
Di Mauro, MG
Muraca, MG
Del Vecchio, M
Pinto, C
D'Aiuto, G
Boni, C
Campa, T
Magni, A
Miceli, R
Perloff, M
Malone, WF
Sporn, MB
Citation: U. Veronesi et al., Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer, J NAT CANC, 91(21), 1999, pp. 1847-1856
Authors:
Honda, T
Rounds, BV
Bore, L
Favaloro, FG
Gribble, GW
Suh, N
Wang, YP
Sporn, MB
Citation: T. Honda et al., Novel synthetic oleanane triterpenoids: A series of highly active inhibitors of nitric oxide production in mouse macrophages, BIOORG MED, 9(24), 1999, pp. 3429-3434
Authors:
Suh, N
Wang, YP
Williams, CR
Risingsong, R
Gilmer, T
Willson, TM
Sporn, MB
Citation: N. Suh et al., A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis, CANCER RES, 59(22), 1999, pp. 5671-5673
Authors:
Suh, NJ
Wang, YP
Honda, T
Gribble, GW
Dmitrovsky, E
Hickey, WF
Maue, RA
Place, AE
Porter, DM
Spinella, MJ
Williams, CR
Wu, GF
Dannenberg, AJ
Flanders, KC
Letterio, JJ
Mangelsdorf, DJ
Nathan, CF
Nguyen, L
Porter, WW
Ren, RF
Roberts, AB
Roche, NS
Subbaramaiah, K
Sporn, MB
Citation: Nj. Suh et al., A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity, CANCER RES, 59(2), 1999, pp. 336-341
Authors:
Alberts, DS
Colvin, GM
Conney, AH
Ernster, VL
Garber, JE
Greenwald, P
Gudas, LJ
Hong, WK
Kelloff, GJ
Kramer, RA
Lerman, CE
Mangelsdorf, DJ
Matter, A
Minna, JD
Nelson, WG
Pezzuto, JM
Prendergast, F
Rusch, VW
Sporn, MB
Wattenberg, LW
Weinstein, IB
Citation: Ds. Alberts et al., Prevention of cancer in the next millennium: Report of the ChemopreventionWorking Group to the American Association for Cancer Research, CANCER RES, 59(19), 1999, pp. 4743-4758